SynDaver is seeking accredited investors for our current private offering. Minimum investment is $100,000.
SynDaver is a mission-driven company from top to bottom. Our customers come first, our employees second, and our investors third. Some people might find it odd that we would point this out on our investor page. However, because of this approach our products are by far the best in the industry, our employees love working here, and our sales are growing at a rapid rate. THIS is how you build shareholder value and sustainable growth at the same time.
SynDaver designs and builds the world’s most sophisticated synthetic human and animal bodies. Our products are used across a wide range of industries, from medical device testing and surgical training to consumer product development and crash testing.
Our customer base is broad, diverse, and global. We sell to every Fortune 500 medical device manufacturer, the best hospitals and medical schools in the world, and educational institutions with EMT, nursing, anatomy, veterinary medicine, dentistry, engineering, mortuary science, surgical technician, physical therapy and sports science programs. We now even sell to middle and high-school biology programs.
Our educational customers include thousands of the best post-secondary institutions in the world, including Beijing Science and Technology University (China), Harvard, MIT, Oxford (UK), Stanford, Yale, and many others.
Our industrial customers include the elite of global technology; firms such as Apple, Ford, General Electric, Google, Lear, Microsoft, Nike, Procter and Gamble, Underwriters Laboratories (UL) and many others.
Our government customers include the U.S. Food and Drug Administration, the U.S. Consumer Product Safety Commission, the U.S. State Department, the Health Services of Canada and the UK, and every branch of the U.S. military. We also sell to NATO, the People’s Liberation Army (China) and allied militaries worldwide.
Our media customers include ABC, AMC, CBS, NBC, PBS and The Discovery Channel. Our products have been seen on too many news programs to list, as well as “Shark Tank” (ABC and CNBC), “Grey’s Anatomy” (ABC), “CSI” (CBS), “Mythbusters” (Discovery), “Mythbusters 2.0” (Science Channel), “Crossbones” (NBC), “Shipping Wars” (AMC) and “Quest” (PBS).
Research and Development
SynDaver is constantly refining technologies, seeking new markets for existing products, and designing new products for emerging applications. In 2017 we launched SynDaver Canine for the veterinary medical education community and in 2018 will launch “CopyCat” a synthetic feline designed for middle and high-school biology programs.
In addition, January 2018 we launched the SynDaver Advanced Modular Mannequin (SAMM), an open-sourced modular mannequin that comes with a 3D printer to allow the end-user to modify the mannequin according to their own desires. SAMM is the best entry-level procedural trainer on the market and also the only open-source product in its class.
Finally, over the next decade we plan on using our disruptive technology to claim a much larger share of the $2 Billion healthcare simulation market.
SynDaver has been in business for approximately 14 years, and over the most recent four year period the company has grown on average more than 70% annually. The company is on track to at least triple (and possibly quintuple) in size this year.
Plans for Growth
SynDaver is developing the third-generation (3G) version of the SynDaver Synthetic Human and is also developing newborn, preemie, and pediatric versions of the synthetic human product line. These models will enable surgical training in the neonatal and pediatric space in a way that is currently not possible without risking an actual human life.
The company is developing military-specific versions of our surgical canine model. The standard version is permanently in use at the University of Florida, Texas A&M, the University of Saskatchewan and many other schools, where it has completely replaced the use of both live dogs and canine cadavers in surgical education programs! The company is already working on additional animal models including cat, horse and rabbit.
SynDaver recently acquired Lifecast Body Simulation in the United Kingdom. The former Lifecast facility in London will be the hub for the newly formed SynDaver Europe. Over the next 12 months we expect to open new facilities in China and Brazil as well.
Finally, the company recently began offering leasing terms and extended financing options for many of our most popular simulators. This will significantly increase our potential customer base in the education marketplace.
Dr. Christopher Sakezles is the founder, CEO, Chief Technology Officer, and Chairman of the Board of Directors for SynDaver. The company is advised by a team of experts drawn from the medical device industry as well as thought leaders in surgical simulation and medical education.
Significant Recent Hires
President, SynDaver Europe – Kevin King
Senior Vice President of Operations – Bill Wright
Vice President of Global Sales – Mark Owens
Vice President of Veterinary Technologies – Dr. David Danielson
Director of Supply Chain and Business Systems – Sam Olsen
Director of Employee Benefits and Resources – Stacey Rodriguez
Manager of Veterans Outreach – Broc Hooten
Expected Upcoming Hires:
Vice President, Marketing
SynDaver Labs periodically offers a variety of investment vehicles via private offering. Please note that we verify identity and require a nondisclosure agreement before a prospectus is issued. To be considered please fill out the form below. Our investment minimum is $100,000 USD.